Shopping Cart
Remove All
Your shopping cart is currently empty
Product Description- A unique collection of 1580 NMPA-approved drugs, ideal for high-throughput screening (HTS) and high-content screening (HCS).
- All compounds are officially approved by the NMPA and accompanied by their corresponding NMPA approval numbers, making this library a powerful tool for drug repurposing and novel target identification.
- Each compound has undergone rigorous preclinical studies and clinical trials, ensuring well-established biological activity and safety.
- Spans multiple therapeutic areas, including oncology, cardiovascular diseases, anti-inflammatory agents, immunomodulators, central nervous system (CNS) drugs, respiratory therapeutics, and more.
- Features structurally diverse compounds with potent pharmacological activity and excellent cell permeability.
- Comprehensive documentation provided for each compound, including chemical structure, target information, IC₅₀ values, and detailed activity descriptions.
- Compound identity and high purity are verified using multiple analytical techniques—including NMR、HPLC/LCMS—minimizing the risk of false positives.
Packaging And Storage
Supporting Files
Feedback
